Telomir Pharmaceuticals, Inc.
TELO
$1.45
-$0.05-3.33%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 87.17% | -68.17% | 51.70% | -55.70% | -42.46% |
Total Receivables | -- | -- | -- | -- | 0.00% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -14.63% | 52.33% | -25.10% | -11.96% | -11.13% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 68.89% | -62.90% | 27.06% | -50.42% | -40.00% |
|
|||||
Total Current Assets | 68.89% | -62.90% | 27.06% | -50.42% | -40.00% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 68.89% | -62.90% | 27.06% | -50.42% | -40.00% |
|
|||||
Total Accounts Payable | -54.37% | -4.87% | 15.99% | 28.62% | 77.71% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 0.00% | 0.00% | 0.00% | -33.43% | 1,675.95% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -46.59% | -4.21% | 13.52% | 12.30% | 9.78% |
|
|||||
Total Current Liabilities | -46.59% | -4.21% | 13.52% | 12.30% | 9.78% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 0.00% | 0.00% | 0.00% | -33.43% | 1,675.95% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -46.59% | -4.21% | 13.52% | 12.30% | 9.78% |
|
|||||
Common Stock & APIC | 17.51% | 4.40% | 11.01% | 20.59% | 0.00% |
Retained Earnings | -15.47% | -7.12% | -10.46% | -27.25% | -7.13% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 398.70% | -125.05% | 45.44% | -71.80% | -48.03% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 398.70% | -125.05% | 45.44% | -71.80% | -48.03% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 398.70% | -125.05% | 45.44% | -71.80% | -48.03% |
|